Patent details

Basic Information

Publication number:

EP2571855

PCT Application Number:

PCT/US/2011/036161

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117839803

PCT Publication Number:

WO/2011/146300

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

French Title of Invention:

NOUVEAUX INHIBITEURS DE PROLYLCARBOXYPEPTIDASE

German Title of Invention:

NEUARTIGE PROLYLCARBOXYPEPTIDASE-HEMMER

SPC Number:

Dates

Filing date:

12/05/2011

Grant date:

24/12/2014

EP Publication Date:

24/12/2014

PCT Publication Date:

24/11/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/03/2013

EP B1 Publication Date:

24/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/05/2015

Expiration date:

12/05/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/05/2011

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

DEBENHAM John, S.

Address:

United States (US)

2

Name:

GRAHAM Thomas, H.

Address:

United States (US)

3

Name:

SHEN Dong-Ming

Address:

United States (US)

4

Name:

ZHANG Yong

Address:

United States (US)

5

Name:

CLEMENTS Matthew, J.

Address:

United States (US)

Priority

Priority Number:

34530310 P

Priority Date:

17/05/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 235/02;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages